Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this widespread impact, many sufferers find current preventive treatments ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

A small trial found that taking the GPL-1 medication liraglutide reduced headache frequency in people with obesity.

Wegovy and Ozempic users on Reddit say these methods have been helpful, even though it can be tough when these drugs cause you to have little desire to eat or drink, well, much of anything.

Stock image of weight loss pills. celsopupo/iStock / Getty Images Plus GLP-1 agonists like Ozempic work, in part, by altering gut-brain signals to decrease hunger; however, their side effects can ...

Over 12 weeks, 26 patients suffering frequent migraines and obesity received a daily dose of the GLP-1 agonist liraglutide. Remarkably, the average number of migraine days per month fell sharply ...